Insulin Enhances the In Vitro Osteogenic Capacity of Flexor Tendon-Derived Progenitor Cells

There is increased incidence of tendon disorders and decreased tendon healing capacity in people with diabetes mellitus (DM). Recent studies have also suggested pathological ossification in repair tendon of people with DM. Therefore, the objective of this study is to investigate the effects of insul...

Full description

Saved in:
Bibliographic Details
Main Authors: Sushmitha S. Durgam, Nadine N. Altmann, Haley E. Coughlin, Audrey Rollins, Laura D. Hostnik
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2019/1602751
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849403633348640768
author Sushmitha S. Durgam
Nadine N. Altmann
Haley E. Coughlin
Audrey Rollins
Laura D. Hostnik
author_facet Sushmitha S. Durgam
Nadine N. Altmann
Haley E. Coughlin
Audrey Rollins
Laura D. Hostnik
author_sort Sushmitha S. Durgam
collection DOAJ
description There is increased incidence of tendon disorders and decreased tendon healing capacity in people with diabetes mellitus (DM). Recent studies have also suggested pathological ossification in repair tendon of people with DM. Therefore, the objective of this study is to investigate the effects of insulin supplementation, an important pathophysiologic stimulus of DM, on tendon progenitor cell (TPC) proliferation and in vitro osteogenic capacity. Passage 3 TPCs were isolated from collagenase-digested, equine superficial digital flexor tendons. TPC proliferation was measured via MTT assay after 3 days of monolayer culture in medium supplemented with 0, 0.007, 0.07, and 0.7 nM insulin. In vitro osteogenic capacity of TPCs (Alizarin Red staining, osteogenic mRNA expression, and alkaline phosphatase bioactivity) was assessed with 0, 0.07, and 0.7 nM insulin-supplemented osteogenic induction medium. Insulin (0.7 nM) significantly increased TPC proliferation after 3 days of monolayer culture. Alizarin Red staining of insulin-treated TPC osteogenic cultures demonstrated robust cell aggregation and mineralized matrix secretion, in a dose-dependent manner. Runx2, alkaline phosphatase, and Osteonectin mRNA and alkaline phosphatase bioactivity of insulin-treated TPC cultures were significantly higher at day 14 of osteogenesis compared to untreated controls. Addition of picropodophyllin (PPP), a selective IGF-I receptor inhibitor, mitigated the increased osteogenic capacity of TPCs, indicating that IGF-I signaling plays an important role. Our findings indicate that hyperinsulinemia may alter TPC phenotype and subsequently impact the quality of repair tendon tissue.
format Article
id doaj-art-85276bc09fcb4c79ba37be63243a742b
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-85276bc09fcb4c79ba37be63243a742b2025-08-20T03:37:12ZengWileyStem Cells International1687-966X1687-96782019-01-01201910.1155/2019/16027511602751Insulin Enhances the In Vitro Osteogenic Capacity of Flexor Tendon-Derived Progenitor CellsSushmitha S. Durgam0Nadine N. Altmann1Haley E. Coughlin2Audrey Rollins3Laura D. Hostnik4Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, 601 Vernon L. Tharp Street, Columbus, OH, 43210, USADepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, 601 Vernon L. Tharp Street, Columbus, OH, 43210, USADepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, 601 Vernon L. Tharp Street, Columbus, OH, 43210, USADepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, 601 Vernon L. Tharp Street, Columbus, OH, 43210, USADepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, 601 Vernon L. Tharp Street, Columbus, OH, 43210, USAThere is increased incidence of tendon disorders and decreased tendon healing capacity in people with diabetes mellitus (DM). Recent studies have also suggested pathological ossification in repair tendon of people with DM. Therefore, the objective of this study is to investigate the effects of insulin supplementation, an important pathophysiologic stimulus of DM, on tendon progenitor cell (TPC) proliferation and in vitro osteogenic capacity. Passage 3 TPCs were isolated from collagenase-digested, equine superficial digital flexor tendons. TPC proliferation was measured via MTT assay after 3 days of monolayer culture in medium supplemented with 0, 0.007, 0.07, and 0.7 nM insulin. In vitro osteogenic capacity of TPCs (Alizarin Red staining, osteogenic mRNA expression, and alkaline phosphatase bioactivity) was assessed with 0, 0.07, and 0.7 nM insulin-supplemented osteogenic induction medium. Insulin (0.7 nM) significantly increased TPC proliferation after 3 days of monolayer culture. Alizarin Red staining of insulin-treated TPC osteogenic cultures demonstrated robust cell aggregation and mineralized matrix secretion, in a dose-dependent manner. Runx2, alkaline phosphatase, and Osteonectin mRNA and alkaline phosphatase bioactivity of insulin-treated TPC cultures were significantly higher at day 14 of osteogenesis compared to untreated controls. Addition of picropodophyllin (PPP), a selective IGF-I receptor inhibitor, mitigated the increased osteogenic capacity of TPCs, indicating that IGF-I signaling plays an important role. Our findings indicate that hyperinsulinemia may alter TPC phenotype and subsequently impact the quality of repair tendon tissue.http://dx.doi.org/10.1155/2019/1602751
spellingShingle Sushmitha S. Durgam
Nadine N. Altmann
Haley E. Coughlin
Audrey Rollins
Laura D. Hostnik
Insulin Enhances the In Vitro Osteogenic Capacity of Flexor Tendon-Derived Progenitor Cells
Stem Cells International
title Insulin Enhances the In Vitro Osteogenic Capacity of Flexor Tendon-Derived Progenitor Cells
title_full Insulin Enhances the In Vitro Osteogenic Capacity of Flexor Tendon-Derived Progenitor Cells
title_fullStr Insulin Enhances the In Vitro Osteogenic Capacity of Flexor Tendon-Derived Progenitor Cells
title_full_unstemmed Insulin Enhances the In Vitro Osteogenic Capacity of Flexor Tendon-Derived Progenitor Cells
title_short Insulin Enhances the In Vitro Osteogenic Capacity of Flexor Tendon-Derived Progenitor Cells
title_sort insulin enhances the in vitro osteogenic capacity of flexor tendon derived progenitor cells
url http://dx.doi.org/10.1155/2019/1602751
work_keys_str_mv AT sushmithasdurgam insulinenhancestheinvitroosteogeniccapacityofflexortendonderivedprogenitorcells
AT nadinenaltmann insulinenhancestheinvitroosteogeniccapacityofflexortendonderivedprogenitorcells
AT haleyecoughlin insulinenhancestheinvitroosteogeniccapacityofflexortendonderivedprogenitorcells
AT audreyrollins insulinenhancestheinvitroosteogeniccapacityofflexortendonderivedprogenitorcells
AT lauradhostnik insulinenhancestheinvitroosteogeniccapacityofflexortendonderivedprogenitorcells